about
Macrophages and Uveitis in Experimental Animal ModelsNK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis.Dietary Omega-3 Fatty Acids Suppress Experimental Autoimmune Uveitis in Association with Inhibition of Th1 and Th17 Cell FunctionEnvironmental microbes and uveitis: is microbial exposure always bad?Autoimmune and autoinflammatory mechanisms in uveitis.Use of optical coherence tomography and electroretinography to evaluate retinal pathology in a mouse model of autoimmune uveitis.Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein.Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis.Comparative Proteomic Analysis of Two Uveitis Models in Lewis RatsCharacterization of a New Epitope of IRBP That Induces Moderate to Severe Uveoretinitis in Mice With H-2b HaplotypeImmune mechanisms in inflammatory and degenerative eye disease.A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization2-Methoxyestradiol Alleviates Experimental Autoimmune Uveitis by Inhibiting Lymphocytes Proliferation and T Cell Differentiation.AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-κB and STAT3 PathwaysSOCS1 Mimetic Peptide Suppresses Chronic Intraocular Inflammatory Disease (Uveitis).In Vivo Bioluminescence Imaging for Longitudinal Monitoring of Inflammation in Animal Models of Uveitis.Biologic agents in experimental autoimmune uveitis.MicroRNAs in retina during development of experimental autoimmune uveoretinitis in rats.Autoimmune uveitis: clinical, pathogenetic, and therapeutic features.Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development.T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex.Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis.Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis.Complement Component C4 Regulates the Development of Experimental Autoimmune Uveitis through a T Cell-Intrinsic Mechanism.Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis.NK cells are negatively regulated by sCD83 in experimental autoimmune uveitisRetinal antigen-specific regulatory T cells protect against spontaneous and induced autoimmunity and require local dendritic cells.A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis.Immunological and pathological investigations in equine experimental uveitis.Complement-Mediated Activation of the NLRP3 Inflammasome and Its Inhibition by AAV-Mediated Delivery of CD59 in a Model of Uveitis.Comparison of Aqueous and Vitreous Lymphocyte Populations From Two Rat Models of Experimental Uveitis.Subretinal Transplantation of Human Amniotic Epithelial Cells in the Treatment of Autoimmune Uveitis in Rats
P2860
Q26828497-22153BA2-5DA9-4863-B1CF-2D5968440823Q27308853-32ACFD6C-4DEB-4532-BF0E-A34EE4E1C786Q27317293-3B95C9DD-4954-448F-89D0-A091638F8FCDQ28086831-79D27EB0-480C-486F-B9BA-13FFE693EA69Q34294964-A0E4ADBA-F561-43FC-A968-BF0CE0E14765Q34731124-294C771C-1CA8-4CBF-8337-33E64799798EQ34981390-B56153E2-5CC3-4E10-8B9D-5227C3A5EB35Q35694141-53874A12-4140-49E0-B50F-CEEDA61231E4Q35889289-CC4201DE-09C8-4BC2-80BE-12C87733A9D4Q35980028-8DE179F2-681F-486B-B75A-DB487D0AC24BQ36040908-CE5C5DAE-0DAD-4631-A58A-EB715A42320FQ36319263-2011AF59-F0B5-4EB4-BDDE-881AE8860B19Q36924163-202AC3FC-B608-491E-93CE-57FF0B3FE13EQ37202385-726F48B1-E0DA-4AEC-9452-081B87A49830Q37293409-B68C4B63-12E0-4D49-80CA-D24026C2ED2AQ37715374-D96D5025-9425-4020-A48B-418484E3C598Q38089645-31963D9B-A4DA-499D-AAC9-357FAD89271CQ38295501-259F711B-A1FD-47EB-97AA-4945E76A9C9CQ38395263-5C8EFEEB-2DF3-43AD-9698-D53D76611646Q38660708-DFD832C3-9C9B-42B7-A571-2C1D36A3FC51Q39689800-7FC36017-B234-4C10-ABBB-A9919BD94D7DQ40075215-D7B501F3-8C2E-4F10-A13D-E1C3E3C28041Q40609980-6D3CEE01-EC43-42C5-98DE-A4FA1276BC99Q41684149-D532E447-8AFD-4E37-B58F-F7942EAB377BQ41989317-D2D6F256-740F-451A-9532-E6ABCDAF3999Q42378981-F1822F36-AD73-4C07-A01C-6AF2E0252BC7Q43068922-ACDB2385-6985-4B28-AEC1-F9161B13611DQ49395944-607C8036-D7A9-4D8D-BD7A-3860660BFA82Q51681606-002EE1E4-C2FF-45AA-94D6-39AE884B9531Q52313908-AB36ED4A-D5AE-4477-B21A-9AC48CC8FFC3Q55262078-747FB02C-0C20-404C-8F91-56ABE54009E6Q57071521-E1908974-AD10-4687-BA38-AD34EE479F80
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rodent models of experimental autoimmune uveitis.
@en
Rodent models of experimental autoimmune uveitis.
@nl
type
label
Rodent models of experimental autoimmune uveitis.
@en
Rodent models of experimental autoimmune uveitis.
@nl
prefLabel
Rodent models of experimental autoimmune uveitis.
@en
Rodent models of experimental autoimmune uveitis.
@nl
P2860
P1476
Rodent models of experimental autoimmune uveitis.
@en
P2093
Phyllis B Silver
Rajeev K Agarwal
P2860
P304
P356
10.1007/978-1-60761-720-4_22
P407
P577
2012-01-01T00:00:00Z